Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 47Carcinoma, Non-Small-Cell Lung 14Neoplasm Metastasis 11Neoplasms 9Colorectal Neoplasms 8Breast Neoplasms 8Triple Negative Breast Neoplasms 7Lung Neoplasms 6Sarcoma 5Melanoma 4Esophageal Neoplasms 3Cholangiocarcinoma 3Brain Neoplasms 3Thyroid Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Pancreatic Diseases 2Gastrointestinal Neoplasms 2Carcinoma 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1TNBC 1Solid Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1

Interventions

Nivolumab 7toripalimab 5Injections 5tislelizumab 3pembrolizumab 3spartalizumab 2sintilimab 2osimertinib 2Paclitaxel 2Ipilimumab 2Gemcitabine 2Cisplatin 2Carboplatin 2zimberelimab 1ulocuplumab 1sotorasib 1famitinib 1donafenib 1cemiplimab 1binimetinib 1avelumab 1atezolizumab 1WW Domain-Containing Oxidoreductase 1Taxes 1SHR-1701 1Oxaliplatin 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1LY-2157299 1Immunotherapy, Adoptive 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Solid Tumor × 130-nm albumin-bound paclitaxel × Clear all
NCT05982522 2026-03-27

IN10018 Combination Therapy in Previously-treated Solid Tumors

InxMed (Shanghai) Co., Ltd.

Phase 1/2 Withdrawn
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡